These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

111 related items for PubMed ID: 20113216

  • 1. Cystatin C and cardiac hypertrophy in primary hypertension.
    Prats M, Font R, Bardají A, Gutierrez C, Lalana M, Vilanova A, Martinez-Vea A.
    Blood Press; 2010 Feb; 19(1):20-5. PubMed ID: 20113216
    [Abstract] [Full Text] [Related]

  • 2. Effect of olmesartan medoxomil on cystatin C level, left ventricular hypertrophy and diastolic function.
    Albayrak S, Ordu S, Ozhan H, Yazici M, Aydin M, Alemdar R, Kaya A.
    Blood Press; 2009 Feb; 18(4):187-91. PubMed ID: 19521888
    [Abstract] [Full Text] [Related]

  • 3. Genetic predisposition to left ventricular hypertrophy and the potential involvement of cystatin-C in untreated hypertension.
    Tousoulis D, Androulakis E, Papageorgiou N, Miliou A, Chatzistamatiou E, Oikonomou E, Moustakas G, Kallikazaros I, Stefanadis C.
    Am J Hypertens; 2013 May; 26(5):683-90. PubMed ID: 23479071
    [Abstract] [Full Text] [Related]

  • 4. Serum cystatin C level is associated with left atrial enlargement, left ventricular hypertrophy and impaired left ventricular relaxation in patients with stage 2 or 3 chronic kidney disease.
    Sakuragi S, Ichikawa K, Yamada K, Tanimoto M, Miki T, Otsuka H, Yamamoto K, Kawamoto K, Katayama Y, Tanakaya M, Ito H.
    Int J Cardiol; 2015 May; 190():287-92. PubMed ID: 25932809
    [Abstract] [Full Text] [Related]

  • 5. Inverse association of estimated cystatin C- and creatinine-based glomerular filtration rate with left ventricular mass: Results from the Study of Health in Pomerania.
    Aumann N, Baumeister SE, Werner A, Wallaschofski H, Hannemann A, Nauck M, Rettig R, Felix SB, Dörr M, Völzke H, Lieb W, Stracke S.
    Int J Cardiol; 2013 Sep 10; 167(6):2786-91. PubMed ID: 22884092
    [Abstract] [Full Text] [Related]

  • 6. Estimated glomerular filtration rate by serum cystatin C correlates with cardiometabolic parameters in patients with primary hyperparathyroidism.
    Ermetici F, Filopanti M, Verga U, Passeri E, Dito G, Malavazos AE, Mapelli C, Raggi ME, Spada A, Corbetta S.
    Eur J Endocrinol; 2015 Oct 10; 173(4):441-6. PubMed ID: 26194503
    [Abstract] [Full Text] [Related]

  • 7. [Is there a relationship between cystatin C and inflammatory status, oxidative stress and other cardiovascular risk factors in non-diabetic patients with chronic kidney disease?].
    Font R, Prats M, Gutiérrez C, Bardají A, Lalana M, Marsillach J, Camps J, Martínez Vea A.
    Nefrologia; 2009 Oct 10; 29(3):228-35. PubMed ID: 19554056
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Comparison of serum levels of Cystatin-C and traditional renal biomarkers for the early detection of pre-hypertensive nephropathy.
    Wali U, Hussain MM, Wali N, Nadeem A, Majeed F.
    J Pak Med Assoc; 2019 Mar 10; 69(3):313-319. PubMed ID: 30890820
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Cystatin C as a mortality predictor in a hypertensive population in Extremadura, Spain].
    Garcia Gallego F, Robles NR, Matias Orozco N, Mena C, Cidoncha A.
    Med Clin (Barc); 2015 Sep 07; 145(5):198-200. PubMed ID: 26051437
    [Abstract] [Full Text] [Related]

  • 18. Preprocedure and Postprocedure Predictive Values of Serum β2-Microglobulin for Contrast-Induced Nephropathy in Patients Undergoing Coronary Computed Tomography Angiography: A Comparison With Creatinine-Based Parameters and Cystatin C.
    Li S, Zheng Z, Tang X, Peng L, Luo Y, Dong R, Zhao Y, Liu J.
    J Comput Assist Tomogr; 2015 Sep 07; 39(6):969-74. PubMed ID: 26248154
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Cystatin C, vascular biomarkers and measured glomerular filtration rate in patients with unresponsive hypertensive phenotype: a pilot study.
    Čabarkapa V, Ilinčić B, Đerić M, Vučaj Ćirilović V, Kresoja M, Žeravica R, Sakač V.
    Ren Fail; 2017 Nov 07; 39(1):203-210. PubMed ID: 27876431
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.